VM is in the Pharma business, not miningThe Willis brothers made a strategic decision to move away from basic mining and enter a specific Pharmaceutical niche where they will enjoy a clear cost competitive advantage plus offer radiocontrast clients a non China option. They will soon start generating cash flow by start selling by mid 2022 a portion of their product line in Canada using third party sourcing. Long term, they will significanly improve margins by developing their own API minerals source (Francis Creek) and GMP plant scheduled to start production by mid 2023.
I like their understated management process.They had promised the Market their PEA early 2022 and they delivered!! I will bet that the Preliminary Feasibility Report will be delivered before the date promised in the presentation.Also, I am really impressed with the industry consultants supporting VM.
https://voyageurpharmaceuticals.ca/wp-content/uploads/2021/09/Voyageur-Investor-Deck-Oct-2021.pdf